Literature DB >> 22298689

Nicotine-induced hypothermia through an indirect dopaminergic mechanism.

M R Zarrindast1, A Zarghi, A Amiri.   

Abstract

The effect of nicotine on core body temperature was studied in mice. Intraperitoneal (i.p.) injection of nicotine (0.5, 1 and 2 mg/kg) induced a dose-dependent hypothermia. The response was inhibited by reserpine (5 mg/kg), the centrally active nicotinic receptor antagonist mecamylamine (0.1-1 mg/kg) and the D-2 dopamine receptor antagonist sulpiride (25-100 mg/kg). The β-adrenoceptor antagonist propranolol (5 and 10 mg/kg) and the serotonergic blocker methysergide (5 and 10 mg/kg) did not inhibit but increased the nicotine response. The α-adrenoceptor antagonist phenoxybenzamine, the antimuscarinic agent atropine, the D-1 dopamine receptor antagonist SCH 23390, the peripheral dopamine antagonist domperidone and the peripheral nicotinic antagonist hexamethonium did not alter the nicotine-induced hypothermia. It is concluded that nicotine may cause a fall in core body temperature through a central dopaminergic mechanism.

Entities:  

Year:  1995        PMID: 22298689     DOI: 10.1177/026988119500900104

Source DB:  PubMed          Journal:  J Psychopharmacol        ISSN: 0269-8811            Impact factor:   4.153


  2 in total

1.  Effects of the sazetidine-a family of compounds on the body temperature in wildtype, nicotinic receptor β2-/- and α7-/- mice.

Authors:  Edward D Levin; Hannah G Sexton; Karen Gordon; Christopher J Gordon; Yingxian Xiao; Kenneth J Kellar; Venkata Mahidhar Yenugonda; Yong Liu; Michael P White; Mikell Paige; Milton L Brown; Amir H Rezvani
Journal:  Eur J Pharmacol       Date:  2013-09-12       Impact factor: 4.432

2.  Multigenerational nicotine exposure affects offspring nicotine metabolism, nicotine-induced hypothermia, and basal corticosterone in a sex-dependent manner.

Authors:  Dana Zeid; Lisa R Goldberg; Laurel R Seemiller; Sean Mooney-Leber; Philip B Smith; Thomas J Gould
Journal:  Neurotoxicol Teratol       Date:  2021-03-13       Impact factor: 3.763

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.